UBS Maintains Neutral on Exponent, Lowers Price Target to $72
UBS analyst Joshua Chan maintains Exponent (NASDAQ:EXPO) with a Neutral and lowers the price target from $75 to $72.
Read original at benzingaStocks · News reference
Exponent Q2 EPS $0.06 Misses $0.56 Estimate, Sales $171.612M Beat $147.545M Estimate
Exponent (NASDAQ:EXPO) reported quarterly earnings of $0.06 per share which missed the analyst consensus estimate of $0.56 by 89.29 percent. This is a 88.46 percent decrease over earnings of $0.52 per share from the
Reference details
Connected markets
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
- Source
- benzinga
- Observed
- Jul 30, 2026, 8:07 PM
- Checked
- Jul 30, 2026, 8:06 PM
- Cadence
- Captured once, then retained as an archive reference
- Status
- fresh
Keep reading
Related headlines
JP Morgan Maintains Overweight on Exponent, Raises Price Target to $90
JP Morgan analyst Tomohiko Sano maintains Exponent (NASDAQ:EXPO) with a Overweight and raises the price target from $80 to $90.
Read original at benzingaExponent Sees Q3 FY26 Revenue Before Reimbursements Growth Of 8%-10%; Raises FY26 Revenue Before Reimbursements Growth View To 9%-10%
Read original at benzingaCORRECTION: Exponent Q2 EPS $0.60 Beats $0.56 Estimate, Sales $171.612M Beat $147.545M Estimate
Read original at benzinga